contraindications for semaglutide for weight loss Semaglutide- in obesity Who Should Not Take Semaglutide?

07 Oct Weight loss Drugs and Their Potential Side Effects: What to Look Out For In recent years, weight-loss drugs have transformed the landscape of weight management, offering hope to individuals struggling with overweight or obesity

PMID: 28340347 Zhang C, Xie Y, Chen H, et al

Importantly, comorbid T2DM or elevated peripheral IR accelerate disease progression in AD and PD independently of vascular disease, with higher peripheral IR predicting conversion from mild cognitive impairment to AD (12, 13) and faster motor and cognitive decline in PD (14, 15), thereby implicating IR as a modifier of NDD biology rather than a simple comorbidity

This study found a modest but statistically significant reduction in HbA1c levels overall (i.e., average reduction of 1.1% with a -0.11% ETD at 12 months)

Always disclose your full medication list during your consultation so your provider can ensure safe, effective treatment